Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [11C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier.
Breuil L, Ziani N, Leterrier S, Hugon G, Caillé F, Bouilleret V, Truillet C, Goislard M, El Biali M, Bauer M, Langer O, Goutal S, Tournier N. Breuil L, et al. Among authors: leterrier s. Pharmaceutics. 2022 Nov 30;14(12):2650. doi: 10.3390/pharmaceutics14122650. Pharmaceutics. 2022. PMID: 36559144 Free PMC article.
[11C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier.
Mairinger S, Leterrier S, Filip T, Löbsch M, Pahnke J, Hernández-Lozano I, Stanek J, Tournier N, Zeitlinger M, Hacker M, Langer O, Wanek T. Mairinger S, et al. Among authors: leterrier s. J Cereb Blood Flow Metab. 2024 Jan;44(1):142-152. doi: 10.1177/0271678X231202336. Epub 2023 Sep 20. J Cereb Blood Flow Metab. 2024. PMID: 37728771
Validation of a pharmacological imaging challenge using 11C-buprenorphine and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain.
Soyer A, Leterrier S, Breuil L, Goislard M, Leroy C, Saba W, Thibault K, Bo GD, Bottlaender M, Caillé F, Goutal S, Tournier N. Soyer A, et al. Among authors: leterrier s. Front Neurosci. 2023 May 10;17:1181786. doi: 10.3389/fnins.2023.1181786. eCollection 2023. Front Neurosci. 2023. PMID: 37234261 Free PMC article.
[18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET imaging repurposed for quantitative estimation of blood-brain barrier permeability in a rat model of Alzheimer's disease.
Soyer A, Goutal S, Leterrier S, Marie S, Larrat B, Selingue E, Winkeler A, Sarazin M, Bottlaender M, Tournier N. Soyer A, et al. Among authors: leterrier s. Ann Pharm Fr. 2024 Apr 22:S0003-4509(24)00061-0. doi: 10.1016/j.pharma.2024.04.004. Online ahead of print. Ann Pharm Fr. 2024. PMID: 38657857
Imaging quantitative changes in blood-brain barrier permeability using [18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET in relation to glial cell recruitment in a mouse model of endotoxemia.
Leterrier S, Goutal S, Hugon G, Goislard M, Saba W, Hosten B, Specklin S, Winkeler A, Tournier N. Leterrier S, et al. J Cereb Blood Flow Metab. 2024 Mar 5:271678X241236755. doi: 10.1177/0271678X241236755. Online ahead of print. J Cereb Blood Flow Metab. 2024. PMID: 38441006
Performance and Sensitivity of [99mTc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver.
Hernández-Lozano I, Leterrier S, Mairinger S, Stanek J, Zacher AS, Breyer L, Hacker M, Zeitlinger M, Pahnke J, Tournier N, Wanek T, Langer O. Hernández-Lozano I, et al. Among authors: leterrier s. Mol Pharm. 2024 Feb 5;21(2):932-943. doi: 10.1021/acs.molpharmaceut.3c01036. Epub 2024 Jan 15. Mol Pharm. 2024. PMID: 38225758 Free PMC article.